Management of Neuroendocrine Breast Carcinoma (NEBC): Review of Literature.

Oncol Rev

Division of Hematology and Medical Oncology, University Hospitals Seidman Cancer Center, Cleveland, OH, United States.

Published: February 2024

Extra pulmonary high-grade poorly differentiated neuroendocrine carcinomas (EP-NECs) are rare tumors that usually arise in the gastrointestinal and genitourinary tracts. Primary neuroendocrine carcinoma of the breast (NEBC) is extremely rare, representing less than 0.1% of all breast cancers and less than 1% of neuroendocrine neoplasms. Consequently, they can be misdiagnosed as other types of breast cancer, however, proper immunohistochemical (IHC) studies can assist with making the correct diagnosis. Management of NEBC can be challenging given the paucity of evidence-based literature and should not routinely follow the therapeutic guidelines of other breast cancers. In this article, we review the current literature regarding the management of NEBC.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10884130PMC
http://dx.doi.org/10.3389/or.2024.12114DOI Listing

Publication Analysis

Top Keywords

breast cancers
8
management nebc
8
breast
5
management neuroendocrine
4
neuroendocrine breast
4
breast carcinoma
4
nebc
4
carcinoma nebc
4
nebc review
4
review literature
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!